MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $325,557 | +950.2% | 1,089 | +317.2% | 0.00% | – |
| Q1 2021 | $31,000 | -80.3% | 261 | -80.7% | 0.00% | – |
| Q4 2020 | $157,000 | +220.4% | 1,355 | +233.7% | 0.00% | – |
| Q3 2020 | $49,000 | -53.3% | 406 | -58.5% | 0.00% | – |
| Q2 2020 | $105,000 | +517.6% | 978 | +249.3% | 0.00% | – |
| Q1 2020 | $17,000 | -85.2% | 280 | -77.8% | 0.00% | – |
| Q4 2019 | $115,000 | -68.5% | 1,261 | -70.2% | 0.00% | – |
| Q3 2019 | $365,000 | -85.1% | 4,235 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $2,445,000 | -25.9% | 23,329 | -11.5% | 0.00% | -33.3% |
| Q1 2019 | $3,301,000 | +1526.1% | 26,350 | +1366.3% | 0.00% | – |
| Q4 2018 | $203,000 | -67.3% | 1,797 | -38.0% | 0.00% | – |
| Q3 2018 | $620,000 | -21.9% | 2,898 | +2.0% | 0.00% | -100.0% |
| Q2 2018 | $794,000 | +467.1% | 2,841 | +136.8% | 0.00% | – |
| Q1 2018 | $140,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |